Seqera Labs

Seqera Labs

Seqera Labs was founded in 2018 in Barcelona by Evan Floden and Paolo Di Tommaso, the creators of Nextflow, an open-source workflow orchestration engine that became the de facto standard for computational biology. The firm provides enterprise infrastructure for scientists running massive, reproducible pipelines across cloud and on-premise environments. Wealth origin is publicly undisclosed; the firm operates as a venture-backed company rather than a traditional family office or fund manager. Seqera's core product is Seqera Platform, a control plane that orchestrates data pipelines built on Nextflow. Deployment spans multi-cloud and hybrid environments, with users running workloads on AWS, Google Cloud, and Azure. The firm's technology underpins critical genomic and proteomic research — Moderna used Nextflow in the development of its COVID-19 mRNA vaccine, and NASA's GeneLab project relies on it for space biology experiments. Seqera participates in the bioinformatics toolchain alongside adjacent platforms like nf-core, a community-driven repository of peer-reviewed analysis pipelines. Headquartered in Barcelona, Seqera has disclosed headcount growth but does not report assets under management or total deployment figures. The firm is a commercial software entity, not a fund, and therefore does not operate adjacent investment vehicles, co-investment clubs, or wealth-management structures. In February 2024, Seqera announced a partnership with NVIDIA to accelerate biomedical research pipelines using GPU-accelerated computing (per NVIDIA's official blog, February 2024). The structural differentiator is Seqera's open-source anchor: Nextflow enjoys deep community lock-in across academia, pharma, and biotech, giving Seqera Labs a proprietary on-ramp to enterprise users who already depend on the free tool. This creates a conversion funnel that a purely proprietary competitor cannot replicate — scientists adopt Nextflow for free, and their institutions eventually buy Seqera Platform to manage production workloads, compliance, and collaboration.